President Trump shared a now-deleted, AI-generated video promoting "medbed hospitals" on social media. The video, rooted in a QAnon conspiracy theory, falsely claims the beds can cure diseases. There ...

SANTA CLARA, Calif. & STOCKHOLM, September 29, 2025--(BUSINESS WIRE)--U.S. Oklo Inc. (NYSE: OKLO) ("Oklo") and Sweden’s Blykalla AB ("Blykalla"), both advanced nuclear technology companies, today ...

The Week 3 NFL schedule has an interesting blend of divisional rivalries and cross-conference showdowns. The former has Texans vs. Jaguars, with Jacksonville 1.5-point home favorites in the Week 3 NFL ...

China trials its first advanced tools for AI chipmaking on facebook (opens in a new window) China trials its first advanced tools for AI chipmaking on linkedin (opens in a new window) China trials its ...

Attorney General Pam Bondi pledges to go after "hate speech," saying there's no place for it after Charlie Kirk’s assassination. But that isn't U.S. law under the First Amendment, and Kirk himself ...

Imagine a world where your most complex workflows are not just simplified but entirely reimagined. With the launch of GPT-5, that world is no longer a distant vision, it’s here. This new AI model ...

Since the inception of Next Gen Stats, we have relied on the basic logic of crediting a target in coverage to the closest defender to the receiver when the pass arrives. This method was directionally ...

Morgan Advanced Materials plc (LON:MGAM) has announced that it will pay a dividend of £0.054 per share on the 17th of November. This means the annual payment is 6.2% of the current stock price, which ...

China has proven through its modern fighter jet design that it is ready to take on its Western counterparts in dogfight scenarios. The J-10 defeated French Rafales in the Pak-India combat of May 2025.

Rina-S has received FDA breakthrough therapy designation for advanced endometrial cancer after standard treatments fail, based on promising Phase 1/2 trial results. The RAINFOL-01 trial showed ...

NICE has recommended a new first-line treatment for adults with advanced bladder cancer, marking a significant breakthrough for patients facing this devastating disease. Enfortumab vedotin (also known ...